期刊文献+

常压高氧对淀粉样蛋白前体/早老素1双重转基因小鼠脑内老年斑及β-淀粉样蛋白的影响 被引量:6

The effect of normobaric hyperoxia on senile plaques and beta-amyloid protein in brain of amyloid protein precursor/presenilin 1 double transgenic mouse
原文传递
导出
摘要 目的探讨常压高氧(40%O2,60%空气)处理淀粉样蛋白前体/早老素1(APP/PSl)双重转基因小鼠是否发挥神经保护作用。方法对APP/PSl双重转基因阿尔茨海默病(AD)模型种鼠交配后产下的子代小鼠进行基因分型,待子代达10周龄时,取双重转基因小鼠40只,随机分成A、B、C、D4组,每组10只,A、B2组小鼠喂养于常压高氧中8ICd,A组持续4周,B组持续8周;C、D组喂养于空气中4或8周,分别作为A、B组的对照。高氧处理后采用免疫组织化学、Thioflavin S染色检测小鼠脑组织形态学的变化,Western blot检测APP代谢过程中相关蛋白的表达变化,ELISA定量检测小鼠脑内β-淀粉样蛋白(Aβ)水平的变化。结果免疫组织化学和Thioflavin S染色均显示,与对照组相比,高氧处理组小鼠皮质和海马内老年斑数量明显减少,B组比A组减少更显著。高氧处理组小鼠脑内C99、C83,水平显著高于对照组,Aβ水平明显低于对照组,但各组小鼠脑内全长APP及β位淀粉样前体蛋白裂解酶1(BACEl)蛋白水平无明显改变。ELISA结果提示,B组小鼠海马和皮质内Aβ40[(783.6±97.2)pg/ml]和A%[(175.3±17.1)pg/ml]含量明显低于对照组A‰[(1251.6±42.3)pg/ml,t:9.36,P〈0.01]和Aβ42[(286.8±13.0)pg/ml,t=13.7,P〈0.01]的含量。结论常压高氧处理能显著减少AD模型小鼠脑内Aβ的产生、沉积及老年斑的形成;这种改变可能通过减少Aβ产生或加速Aβ清除实现。 Objective In order to investigate whether normobaric hyperoxia exert neuroprotective effect on amyloid protein prccursor/presenilin 1 (APP/PS1) double transgenic Alzheimer' s disease (AD) mouse model. Methods Forty APP/PS1 double transgenic mice were randomly divided into 4 groups ( A, B, C and D). Mice were treated with 40% oxygen for 8 h per day for4 weeks in group A and for 8 weeks in group B. Group C and group D were given regular air for 4 weeks and 8 weeks, respectively, as controls. Immunohistochemical staining, Thioflavin S staining, Western blot and ELISA assay were performed on mice brain tissues in all groups after the treatment. Results Immuohistochemical and Thioflavin S staining showed that in hyperoxia-treated mice, number and size of senile plaques in the cerebral cortex and hippocampus were notably decreased, and deposition of Aβ in the brain of group B decreased more than that of group A. Western blot revealed that in the hyperoxia-treated mice, the levels of C99 and Cs3 were greatly increased while the Aβ level notably decreased, compared with controls. However, the expression of holoprotein APP and β-site amyloid cleavage enzyme 1 ( BACE1 ) showed no difference among 4 groups. ELISAassay showed that Aβ40 ((783.6 ±97.2) pg/ml) and Aβ42 ((175.3 ± 17.1) pg/ml) were significantly decreased in the brain of 8 weeks hyperoxia-treated mice compared with the control group Aβ40 ( ( 1251.6 ±42. 3 ) pg/ml, t = 9. 36, P 〈 0. 01 ), and Aβ42 ( (286. 8 ± 13.0) pg/ml, t = 13.7, P 〈 0. 01 ). Conclusion Treatment with hyperoxia can significantly decrease Aβ levels and lower the number and size of senile plaques in the brain of APP/PS1 transgenic mouse. This study indicates that hyperoxia may exert its neuroprotective effect through decreasing the generation of Aβ or accelerating the clearance of Aβ.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第3期222-226,共5页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(30700885) 重庆医科大学重点课题资助项目(XBZD200702)
关键词 高压氧 阿尔茨海默病 衰老斑 淀粉样Β蛋白 早老素1 小鼠 转基因 Hyperberic oxygenation Alzheimer disease Senile plaques Amyloid beta- protein Presenilin-1 Mice, transgenic
  • 相关文献

参考文献15

  • 1de la Torre JC.Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data,dogma,and dialectics.Lancet Neurol,2004,3:184-190.
  • 2Cole SL,Vassar R.Linking vascular disorders and Alzheimer's disease:potential involvement of BACE1.Neurobiol Aging,2009,30:1535-1544.
  • 3Koistinaho M,Koistinaho J.Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.Brain Res Brain Res Bey,2005,48:240-250.
  • 4Sun X,He G,Qing H,et al.Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.Proc Natl Acad Sci U S A.2006,103:18727-18732.
  • 5Pathological correlates of late-onset dementia in a multicentre,community-based population in England and Wales.Neuropatholngy Group of the Medical Research Council Cognitive Function and Ageing Study(MRC CFAS).Lancet,2001,357:169-175.
  • 6Pinksten JB,Alekseeva N,González Toledo E.Stroke and dementia.Nettrol Res,2009,31:824-831.
  • 7Marks N,Berg MJ.BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.Neurochem Res,2010,35:181-210.
  • 8Luque FA,Jaffe SL.The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview.Int Bey Neurobiol,2009,84:151-165.
  • 9Selkce DJ,American College of Physicians,American Physiological Society.Alzheimer disease:mechanistic understanding predicts novel therapies.Ann Intern Med,2004,140:627-638.
  • 10Dickey CA,Loring JF,Montgomery J,et al.Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presonilin-1 transgenic mice.J Neurosci,2003,23:5219-5226.

二级参考文献16

  • 1Kalaria RN.The role of cerebral ischemia in Alzheimer's disease.Neurobiol Aging,2000,21:321-330.
  • 2Neuropathology Group,Medical Research Council Cognitive Function and Ageing Study.Pathological correlates of late-onset dementia in a multicentre,community-based population in England and Wales.Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).Lancet,2001,357:169-175.
  • 3de la Torre JC.Alzheimer's disease as a vascular disorder:nosological evidence.Stroke,2002,33:1152-1162.
  • 4Jendroska K,Hoffmann OM,Patt S.Amyloid β-peptide and precursor protein (APP) in mild and severe brain ischemia.Ann NY Acad Sci,1997,826:401-405.
  • 5Lammich S,Kojiro E,Postinqa R,et al.Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.Proc Natl Acad USA,1999,96:3922-3927.
  • 6Tandon A,Rogaeva E,Mullan M,et al.Molecular genetics of Alzheimer's disease:the role of β-amyloid and the presenilins.Curr Opin Neurol,2000,13:377-384.
  • 7Yu AC,Lau LT.Expression of interleukin-1 α,tumor necrosis factor α and interleukin-6 gene in astrocytes under ischemic injury.Neurochem Int,2000,36:363-377.
  • 8Bouaziz N,Redon M,Quere L,et al.Mitochondrial respiratory chain as a new target for anti-ischemic molecules.Eur J Pharmacol,2002,441:35-45.
  • 9Selkoe DJ,American College of Physicians,American Physiological Society.Alzheimer disease:mechanistic understanding predicts novel therapies.Ann Intern Med,2004,40:627-638.
  • 10Murphy T,Yip A,Brayne C,et al.The BACE gene:genomic structure and candidate gene study in late-onset Alzheimer's disease.Neuroreport,2001,12:631-634.

共引文献10

同被引文献76

  • 1严波,王宁宇.阿尔茨海默病患者的嗅觉功能改变[J].中华老年医学杂志,2005,24(2):120-121. 被引量:7
  • 2Muyllaert D, Kremer A, Jaworski T, et al. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? [J]. Genes Brain Behav, 2008,7(S1 ) : 57-66.
  • 3Kockeritz L, Doble B, Patel S, et al. Glycogen synthase kinase- 3--an overview of an over-achieving protein kinase [J]. Curr Drug Targets, 2006,7 ( 11 ) : 1377-1388.
  • 4Bhat RV, Budd Haeberlein SL, Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies [J]. Neurochem, 2004, 89(6) : 1313-1317.
  • 5Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer' s disease[J]. J Neurochem, 2008,104 (6) : 1433 - 1439.
  • 6Williams RS, Cheng L, Mudge AW, et al. A common mechanism of action for three mood-stabilizing drugs [J]. Nature, 2002,417 (6886) : 292-295.
  • 7Dickey CA, Loring JF, Montgomery J, et al. Selectively reduced expression of synaptic plasticity-related genes in amyloid precur- sor protein + presenilin-1 transgenic mice[J].Neurosci, 2003, 23(12) :5219-5226.
  • 8Luque FA, Jaffe SL. The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview [J]. Int Rev Neu- robiol, 2009,84 : 151-165.
  • 9Qing H, He G, Ly PT, et al. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alz- heimer' s disease mouse models [J]. Exp Med, 2008,205 (12) : 2781-2789.
  • 10Deshpande A, Mina E, Glabe C, et al. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons[J]. Neurosci, 2006,26(22) :6011-6018.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部